Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.

Basu D, Gallus A, Hirsh J, Cade J.

N Engl J Med. 1972 Aug 17;287(7):324-7. No abstract available.

PMID:
5041701
2.

Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?

Agnelli G.

Haematologica. 1995 Mar-Apr;80(2 Suppl):78-83. Review. No abstract available.

PMID:
7628776
3.

Anticoagulant therapy in venous thromboembolism.

Hirsh J.

Baillieres Clin Haematol. 1990 Jul;3(3):685-92. Review. No abstract available.

PMID:
2271786
4.

Heparin: an overview.

Maguire FW.

Del Med J. 1979 Aug;51(8):439-49. Review. No abstract available.

PMID:
385374
5.

[Therapeutic strategy in venous thromboembolic disease (VTD)].

[No authors listed]

Arch Bronconeumol. 1994 Dec;30(10):498-505. Review. Spanish. No abstract available.

PMID:
7827764
6.

Antithrombotic therapy in deep vein thrombosis and pulmonary embolism.

Hirsh J.

Am Heart J. 1992 Apr;123(4 Pt 2):1115-22. Review.

PMID:
1553881
7.

Low-dose heparin: an aid to therapy.

Covey TH Jr, Baue AE.

Surg Annu. 1980;12:187-204. Review. No abstract available.

PMID:
6996168
8.

Control of heparin therapy.

Wessler S, Gitel S.

Prog Hemost Thromb. 1976;3:311-29. Review. No abstract available.

PMID:
781735
9.

[Heparin therapy: 1998 (current use of the 80-year-old heparin)].

Rák K.

Orv Hetil. 1999 Jan 10;140(2):59-66. Review. Hungarian.

PMID:
9949661
10.

Antithrombotic drugs: part I.

Gallus AS, Hirsh J.

Drugs. 1976;12(1):41-68. Review.

PMID:
789043
11.

Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.

Carter BL, Jones ME, Waickman LA.

Clin Pharm. 1985 May-Jun;4(3):279-96. Review.

PMID:
3891200
12.

Heparin in the prophylaxis and treatment of venous thromboembolism.

Thomas DP.

Semin Hematol. 1978 Jan;15(1):1-17. Review. No abstract available.

PMID:
341325
13.

Anticoagulants in venous thromboembolism. Prophylactic and therapeutic use.

Hirsh J, Gallus AS.

Postgrad Med. 1974 Jan;55(1):211-7. Review. No abstract available.

PMID:
4588719
14.

Effectiveness of anticoagulants.

Hirsh J.

Semin Thromb Hemost. 1986 Jan;12(1):21-37. Review. No abstract available.

PMID:
3515557
15.

Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.

Kearon C.

Curr Opin Pulm Med. 2007 Sep;13(5):398-402. Review.

PMID:
17940484
16.

Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review.

Lindblad B.

Acta Chir Scand Suppl. 1988;543:31-42. Review. No abstract available.

PMID:
3055779
17.

[Risk and prevention of venous thromboembolic complications in surgery].

Baeshko AA.

Khirurgiia (Mosk). 2001;(4):61-9. Review. Russian. No abstract available.

PMID:
11490498
18.

[Prevention of thromboembolism with a low-dose heparin regimen in acute stroke].

Mück AO, Heinrich F.

Med Klin (Munich). 1992 Aug 15;87(8):422-7. Review. German. No abstract available.

PMID:
1406475
19.

[Low molecular weight heparin in venous thromboembolism. Mechanism of action, therapy and prophylaxis].

Stammler F, Diehm C.

Dtsch Med Wochenschr. 1998 May 8;123(19):604-11. Review. German. No abstract available.

PMID:
9618643
20.

Theory and practice of minidose heparin in surgical patients. A status report.

Wessler S, Yin ET.

Circulation. 1973 Apr;47(4):671-6. Review. No abstract available.

PMID:
4572381

Supplemental Content

Support Center